Stock listing

OTC:CHEOF Cochlear Limited Stock

US listing (OTC) of Cochlear Limited · home listing ASX:COH

Follow Cochlear Limited into a list and get an email when it puts out news.

Share price · OTC:CHEOF

$100.00 USD +2.43 (+2.5%)

Close on Nov 19, 2026

Past year -43.7% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
$100.00 – $100.00 USDNov 19, 2026
Volume
751 sharesNov 19, 2026
Market cap
$6.54B USDAt the close on Nov 19, 2026 · price × 65.40M shares outstanding
52-week range
$64.39 – $197.11 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$7,092 USDMedian day 0 shares · 30 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Cochlear Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:COH · Home$149.99 AUD-3.18 (-2.1%)223,396$153.65$153.68$147.63$153.17Close on Nov 20, 2026
OTC:CHEOY$49.12 USD-1.72 (-3.4%)800$49.75$50.00$49.12$50.84Close on Nov 20, 2026
OTC:CHEOF$100.00 USD+2.43 (+2.5%)751$100.00$100.00$100.00$97.57Close on Nov 19, 2026
Frankfurt:OC5€89.84 EUR-3.62 (-3.9%)36€90.74€90.74€89.84€93.46Close on Nov 20, 2026
Munich:OC5€90.51 EUR-3.18 (-3.4%)—€91.13€91.13€90.51€93.69Close on Nov 20, 2026
Frankfurt:OC50€45.60 EUR-1.00 (-2.1%)—€45.60€45.60€45.60€46.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:CHEOF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$100.110.000.0%$100.11$100.11$100.110
$100.110.000.0%$100.11$100.11$100.110
$100.110.000.0%$100.11$100.11$100.110
$100.110.000.0%$100.11$100.11$100.110
$100.110.000.0%$100.11$100.11$100.110
$100.11+5.49+5.8%$100.11$100.11$100.111,100
$94.620.000.0%$94.62$94.62$94.620
$94.620.000.0%$94.62$94.62$94.620
$94.62+2.62+2.8%$94.78$94.78$94.62200
$92.000.000.0%$92.00$92.00$92.000
$92.000.000.0%$92.00$92.00$92.000
$92.000.000.0%$92.00$92.00$92.000
$92.000.000.0%$92.00$92.00$92.000
$92.000.000.0%$92.00$92.00$92.000
$92.00-1.32-1.4%$92.00$92.00$92.00100
$93.32+2.95+3.3%$93.32$93.32$93.32100
$90.370.000.0%$90.37$90.37$90.370
$90.370.000.0%$90.37$90.37$90.370
$90.37-0.08-0.1%$90.37$90.37$90.37100
$90.450.000.0%$90.45$90.45$90.450
$90.450.000.0%$90.45$90.45$90.450
$90.450.000.0%$90.45$90.45$90.450
$90.45-0.41-0.5%$90.70$90.70$90.45300
$90.86+0.13+0.1%$90.86$90.86$90.86100
$90.73-2.88-3.1%$90.73$90.73$90.73100
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.610.000.0%$93.61$93.61$93.610
$93.61-3.10-3.2%$95.50$95.50$93.61100
$96.710.000.0%$96.71$96.71$96.710
$96.710.000.0%$96.71$96.71$96.710
$96.710.000.0%$96.71$96.71$96.710
$96.71-1.54-1.6%$96.71$96.71$96.71200
$98.25+1.116+1.1%$98.25$98.25$98.25100
$97.13-3.911-3.9%$97.13$97.13$97.1310
$101.05+6.155+6.5%$101.05$101.05$101.05100
$94.89-1.90-2.0%$94.89$94.89$94.89357
$96.79+0.040.0%$96.79$96.79$96.798
$96.75+0.75+0.8%$96.75$96.75$96.75412
$96.00+3.00+3.2%$96.00$96.00$96.0076
Ticker
OTC:CHEOF
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Cochlear Limited news

Cochlear Limited on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
68 in the last 12 months · 184 in all · newest Nov 17, 2026 · oldest 2016
Calls
8 calls with a replay · 8 with a transcript · latest Aug 18, 2026
Decks
86 decks · latest Nov 13, 2026

Where Cochlear Limited is listed

ListingExchangeCountryCurrency
ASX:COH · Home listingASXAustraliaAUD
OTC:CHEOYOTCUnited StatesUSD
OTC:CHEOF · This pageOTCUnited StatesUSD
gettex:OC5gettexGermanyEUR
Tradegate:OC5TradegateGermanyEUR
LS Exchange:898321LS ExchangeGermanyEUR
Lang & Schwarz:898321Lang & SchwarzGermanyEUR
Frankfurt:OC5FrankfurtGermanyEUR
gettex:OC50gettexGermanyEUR
BMV:COHNBMVMexicoMXN
Munich:OC5MunichGermanyEUR
BIVA:COHNBIVAMexicoMXN
BX Swiss:OC5BX SwissSwitzerlandCHF
Dusseldorf:OC5DusseldorfGermanyEUR
Dusseldorf:OC50DusseldorfGermanyEUR
Frankfurt:OC50FrankfurtGermanyEUR
Hamburg:OC5HamburgGermanyEUR
Lang & Schwarz:A1C3B8Lang & SchwarzGermanyEUR
LS Exchange:A1C3B8LS ExchangeGermanyEUR
Munich:OC50MunichGermanyEUR
Stuttgart:OC5StuttgartGermanyEUR

Valuation

P/E 66.6× against a median of 28.6×: 10th lowest of 11 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$9.83B AUD
P/E
66.6×
EV/sales
4.2×
EV/EBITDA
24.2×
Price/book
5.6×
Gross margin
70.5%
Operating margin
12.9%
Net margin
6.3%
Debt to equity
0.1×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Cochlear Limited · ASX:COHUS$6.49BUS$6.51B66.6×4.2×24.2×5.6×6.3%0.1×n/a
Globus Medical, Inc. · NYSE:GMEDUS$7.48BUS$7.07B13.4×2.3×7.4×1.6×17.8%0.0×0.89
Getinge AB Class B · OMXSTO:GETI_BUS$6.88BUS$7.67B24.9×2.3×11.2×2.1×8.2%0.3×n/a
Teleflex Incorporated · NYSE:TFXUS$6.85BUS$8.04B22.5×3.6×20.1×2.0×13.5%0.5×0.50
Ypsomed Holding AG · SIX:YPSNUS$6.80BUS$6.76B25.7×7.8×17.3×7.2×30.4%0.0×n/a
ConvaTec Group PLC · LSE:CTECUS$6.64BUS$8.29B37.9×3.4×15.2×4.6×7.2%1.2×n/a
APT Medical Inc. Class A · SSE:688617US$5.98BUS$5.72B39.3×12.4×n/a11.8×33.0%0.0×n/a
Haemonetics Corporation · NYSE:HAEUS$5.47BUS$6.35B52.7×4.6×22.1×6.1×7.5%1.3×0.27
Merit Medical Systems, Inc. · NASDAQ:MMSIUS$5.05BUS$5.29B31.6×3.3×15.4×2.9×9.9%0.4×0.49
LivaNova PLC · NASDAQ:LIVNUS$5.00BUS$4.73B25.5×3.1×21.6×3.6×13.0%0.2×1.02
Intco Medical Technology Co., Ltd. Class A · SZSE:300677US$4.73BUS$3.55B106×1.8×n/a1.7×2.3%0.0×n/a
Median of the othersUS$6.31BUS$6.55B28.6×3.3×16.4×3.3×11.5%0.3×0.50

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
136.34 AUD · Analysts' mean
EPS, year to Jun 2027
5.20 · 16 analysts
Revenue, year to Jun 2027
2.37B · 16 analysts

Events

Next results
Feb 12, 2027 (expected)

Calls

CallWhenStatus
Cochlear (ASX:COH) Q4 2026 Earnings CallMon, Aug 17, 2026 · 10:00 PM ETReplay
Cochlear (ASX:COH) Q2 2026 Earnings CallFri, Feb 13, 2026 · 3:00 AM ETReplay
Cochlear (ASX:COH) Q4 2025 Earnings CallThu, Aug 14, 2025 · 8:00 PM ETReplay
Cochlear (ASX:COH) Q2 2025 Earnings CallThu, Feb 13, 2025 · 6:00 PM ETReplay
Cochlear (ASX:COH) Q4 2024 Earnings CallWed, Aug 14, 2024 · 8:00 PM ETReplay
Cochlear (ASX:COH) Q2 2024 Earnings CallSun, Feb 18, 2024 · 6:00 PM ETReplay
Cochlear (ASX:COH) Q4 2023 Earnings CallMon, Aug 14, 2023 · 8:00 PM ETReplay
Cochlear (ASX:COH) Q2 2023 Earnings CallTue, Feb 14, 2023 · 6:00 PM ETReplay

Results days

QuarterResultsShare move
Q2 2026Feb 13, 2026−18.4%
Q4 2025Aug 15, 2025 · Before open+1.0%
Q2 2025Feb 13, 2025−14.3%
Q2 2023Feb 15, 2023 · Before open+7.8%
Q4 2022Aug 19, 2022+2.9%
Q2 2022Feb 22, 2022+14.6%
Q4 2021Aug 20, 2021−5.7%
Q2 2021Feb 19, 2021+7.8%

Open Events

Decks

DeckKindSlidesDate
Investor Day (November 2026)Investor day132 slidesNov 13, 2026
Investor Day (November 2026)Investor day134 slidesNov 13, 2026
Cochlear Plc Ord — FY2026 Earnings PresentationEarnings36 slidesAug 18, 2026
Cochlear Plc Ord — HY26 Earnings PresentationEarnings27 slidesFeb 13, 2026
FY2025 Earnings PresentationEarnings37 slidesAug 15, 2025
Cochlear Plc Ord — HY25 Earnings PresentationEarnings26 slidesFeb 14, 2025
Cochlear Plc Ord — FY2024 Earnings PresentationEarnings33 slidesAug 15, 2024
H1 FY2024 Earnings PresentationEarnings26 slidesFeb 19, 2024
Investor Day (October 2023)Investor day115 slidesOct 27, 2023
Investor Day (October 2023)Investor day114 slidesOct 27, 2023
Show 50 decks
DeckKindSlidesDate
FY2023 Earnings PresentationEarnings34 slidesAug 15, 2023
H1 FY2023 Earnings PresentationEarnings39 slidesFeb 15, 2023
FY2022 Earnings PresentationEarnings45 slidesAug 19, 2022
H1 FY2022 Earnings PresentationEarnings48 slidesFeb 22, 2022
Shareholder Meeting (October 2021)Shareholder meeting25 slidesOct 19, 2021
FY2021 Earnings PresentationEarnings49 slidesAug 20, 2021
H1 FY2021 Earnings PresentationEarnings28 slidesFeb 19, 2021
Shareholder Meeting (October 2020)Shareholder meeting29 slidesOct 20, 2020
FY2020 Earnings PresentationEarnings36 slidesAug 18, 2020
Investor Presentation (March 2020)Investor deck35 slidesMar 25, 2020
H1 2020 Earnings PresentationEarnings28 slidesFeb 18, 2020
Shareholder Meeting (October 2019)Shareholder meeting22 slidesOct 22, 2019
Investor Day (May 2019)Investor day55 slidesMay 10, 2019
H1 FY2019 Earnings PresentationEarnings21 slidesFeb 19, 2019
Shareholder Meeting (October 2018)Shareholder meeting17 slidesOct 16, 2018
FY2018 Earnings PresentationEarnings10 slidesAug 14, 2018
Investor Day (May 2018)Investor day54 slidesMay 4, 2018
HY18 Earnings PresentationEarnings11 slidesFeb 13, 2018
Shareholder Meeting (October 2017)Shareholder meeting19 slidesOct 17, 2017
FY2017 Earnings PresentationEarnings13 slidesAug 17, 2017
Investor Day (May 2017)Investor day65 slidesMay 4, 2017
HY17 Earnings PresentationEarnings11 slidesFeb 14, 2017
Shareholder Meeting (October 2016)Shareholder meeting23 slidesOct 18, 2016
FY2016 Earnings PresentationEarnings12 slidesAug 9, 2016
Investor Day (April 2016)Investor day54 slidesApr 28, 2016
H1 2016 Earnings PresentationEarnings12 slidesFeb 11, 2016
Shareholder Meeting (October 2015)Shareholder meeting30 slidesOct 20, 2015
FY2015 Earnings PresentationEarnings16 slidesAug 11, 2015
H1 FY2015 Earnings PresentationEarnings16 slidesFeb 10, 2015
Shareholder Meeting (October 2014)Shareholder meeting29 slidesOct 14, 2014
FY2014 Earnings PresentationEarnings17 slidesAug 5, 2014
H1 FY2014 Earnings PresentationEarnings16 slidesFebruary 2014
Shareholder Meeting (October 2013)Shareholder meeting23 slidesOct 15, 2013
FY2013 Earnings PresentationEarnings17 slidesAug 6, 2013
UBS Australian Healthcare Conference 2013Conference22 slidesJun 17, 2013
H1 FY2013 Earnings PresentationEarnings15 slidesFeb 5, 2013
Shareholder Meeting (October 2012)Shareholder meeting24 slidesOct 16, 2012
FY2012 Earnings PresentationEarnings32 slidesAug 7, 2012
H1 FY2012 Earnings PresentationEarnings31 slidesFeb 7, 2012
Shareholder Meeting (October 2011)Shareholder meeting25 slidesOct 18, 2011

This page holds 50 of 86 decks. Open Decks

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue2.33B2.34B2.24B1.94B1.64B1.49B1.35B1.43B1.36B1.25B
Cost of revenue688.0M615.2M562.1M488.0M411.0M410.2M355.9M351.1M361.2M358.4M
Gross profit1.65B1.73B1.67B1.47B1.23B1.08B1.01B1.08B1.00B895.4M
Research and development323.2M291.5M277.0M244.9M210.7M195.0M185.1M184.4M167.7M151.9M
Selling, general and administrative1.02B207.9M212.6M203.9M159.0M116.1M93.8M94.8M97.4M85.2M
Operating income301.0M406.1M521.5M389.5M361.7M327.9M259.0M352.9M345.2M315.2M
Depreciation and amortization106.0M90.4M84.9M80.9M73.0M76.4M77.5M38.5M34.2M31.2M
EBITDA407.0M496.5M606.4M470.4M434.7M404.3M336.5M391.4M379.4M346.4M
Interest expense13.2M11.0M9.20M9.40M8.60M12.0M10.5M5.20M8.50M7.52M
Income before tax201.0M518.5M484.8M396.8M393.8M363.5M-269.9M365.6M340.5M308.8M
Income tax53.7M129.6M128.0M96.0M104.7M38.0M-32.8M88.9M94.7M85.2M
Net income147.3M388.9M356.8M300.6M289.1M326.5M-238.3M276.7M245.8M223.6M
Earnings per share, basic2.255.945.434.564.404.97-4.004.794.273.89

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents187.7M275.7M513.6M555.5M629.3M609.6M565.0M78.6M61.5M89.5M
Short-term investments102.7M90.8M68.8M27.3M365.0M365.0M3.70M18.4M
Receivables559.2M585.9M490.7M457.5M390.4M296.3M304.9M331.9M316.7M299.4M
Inventory491.3M499.4M391.6M311.5M270.2M216.1M223.8M195.4M167.4M160.0M
Current assets1.30B1.42B1.45B1.36B1.33B1.23B1.48B635.0M584.2M585.9M
Property, plant and equipment536.2M517.2M447.2M439.2M428.5M438.8M166.5M128.4M120.1M
Goodwill265.6M278.6M257.7M256.1M257.1M267.3M270.9M268.8M265.4M267.1M
Total assets2.60B2.83B2.75B2.57B2.47B2.43B2.58B1.38B1.16B1.14B
Accounts payable270.6M298.4M303.2M270.4M232.4M202.9M159.3M160.8M140.5M130.9M
Current liabilities604.5M602.3M631.5M578.0M527.6M402.5M817.5M359.5M287.7M346.6M
Long-term debt045.0M79.9M178.3M144.0M134.2M
Total debt212.7M235.7M243.7M201.8M253.9M264.3M704.5M181.6M147.7M218.9M
Total liabilities862.4M874.7M904.6M819.9M779.4M736.5M1.18B653.3M546.1M592.7M
Shareholders' equity1.74B1.95B1.84B1.75B1.69B1.69B1.40B725.9M610.8M543.6M
Shares outstanding65.5M65.4M65.7M65.9M65.8M65.7M59.6M57.7M57.6M57.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations368.0M237.6M388.8M362.4M376.5M265.4M-157.8M296.0M258.1M259.8M
Capital spending-61.1M-62.4M-62.4M-95.9M-77.2M-66.7M-130.5M-59.9M-28.4M-53.5M
Free cash flow306.9M175.2M326.4M266.5M299.3M198.7M-288.3M236.1M229.7M206.3M
Cash from investing-104.5M-115.2M-105.7M-125.7M-138.9M279.9M-509.7M-137.8M-55.4M-135.6M
Cash from financing-344.1M-366.9M-323.8M-310.4M-220.7M-495.1M1.15B-140.9M-232.7M-108.3M
Dividends paid-281.2M-278.2M-245.7M-197.4M-194.0M-75.6M-193.7M-181.8M-161.1M-143.5M
Share buybacks-26.7M-52.6M-45.8M-29.6M-1.10M399.0M219.4M398.2M-400.0K184.0M
Change in cash-88.0M-237.9M-41.9M-73.8M19.7M44.6M486.4M17.1M-28.0M14.1M

Open Financials

Filings

FilingDateTypeFiled with
Appendix 3Y - Michael del PradoNov 17, 2026Other filingsASX
Appendix 3Y - Diggory HowittNov 17, 2026Other filingsASX
Notification regarding unquoted securities - COHNov 17, 2026Other filingsASX
CMD details, CNA leader change & FY27 guidance reaffirmedNov 12, 2026GuidanceASX
2026 AGM ResultsOct 25, 2026Other filingsASX
2026 AGM Chair and CEO & President AddressesOct 25, 2026Other filingsASX
Ceasing to be a substantial holderOct 22, 2026Ownership change noticeASX
Notification of cessation of securities - COHOct 13, 2026FinancingASX
Notification regarding unquoted securities - COHOct 13, 2026Other filingsASX
Notification regarding unquoted securities - COHOct 13, 2026Other filingsASX
All 162 filings
FilingDateTypeFiled with
Ceasing to be a substantial holderOct 11, 2026Ownership change noticeASX
Change in substantial holdingOct 5, 2026Ownership change noticeASX
Defence of Class Action ProceedingsSep 28, 2026Legal or regulatory actionASX
Cochlear to host Capital Markets DaySep 24, 2026Other filingsASX
Notification regarding unquoted securities - COHSep 23, 2026Other filingsASX
Update - Dividend/Distribution - COHSep 22, 2026DividendASX
Notice of Annual General Meeting & Proxy/Voting FormSep 22, 2026Meeting noticeASX
Appointment of Prof. Ian Meredith to the Cochlear BoardSep 17, 2026Other filingsASX
Change in substantial holdingSep 17, 2026Ownership change noticeASX
Change in substantial holdingSep 6, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 6, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 4, 2026Ownership change noticeASX
S&P DJI Announces September 2026 Quarterly RebalanceSep 4, 2026Other filingsASX
Ceasing to be a substantial holderSep 4, 2026Ownership change noticeASX
Change in substantial holdingSep 3, 2026Ownership change noticeASX
Becoming a substantial holderSep 3, 2026Ownership change noticeASX
Appendix 3Y - Richard FreudensteinSep 2, 2026Other filingsASX
Becoming a substantial holderSep 2, 2026Ownership change noticeASX
Change in substantial holdingSep 2, 2026Ownership change noticeASX
Change in substantial holdingSep 1, 2026Ownership change noticeASX
Ceasing to be a substantial holderAug 28, 2026Ownership change noticeASX
Update - Notification of buy-back - COHAug 27, 2026Treasury share statusASX
Becoming a substantial holderAug 27, 2026Ownership change noticeASX
Appendix 3Y - Michael del PradoAug 26, 2026Other filingsASX
Appendix 3Y - Caroline ClarkeAug 26, 2026Other filingsASX
Change in substantial holdingAug 26, 2026Ownership change noticeASX
Change in substantial holdingAug 26, 2026Ownership change noticeASX
Appendix 3Y - Michael DaniellAug 24, 2026Other filingsASX
Appendix 3Y - Alison DeansAug 24, 2026Other filingsASX
Appendix 3Y - Christine McLoughlinAug 24, 2026Other filingsASX
Appendix 3Y - Karen PenroseAug 24, 2026Other filingsASX
Appendix 3Y - Diggory HowittAug 24, 2026Other filingsASX
Notification of cessation of securities - COHAug 24, 2026FinancingASX
FY26 Result - PresentationAug 17, 2026ResultsASX
Appendix 4GAug 17, 2026Other filingsASX
FY26 Result - ASX & Media ReleaseAug 17, 2026ResultsASX
2026 Tax Contribution ReportAug 17, 2026ESG reportASX
Dividend/Distribution - COHAug 17, 2026DividendASX
Annual ReportAug 17, 2026Annual reportASX
Appendix 4EAug 17, 2026ResultsASX
Date of AGM and closing date for director nominationsAug 16, 2026Meeting noticeASX
Change in substantial holdingAug 14, 2026Ownership change noticeASX
Change in substantial holdingAug 13, 2026Ownership change noticeASX
Becoming a substantial holderAug 12, 2026Ownership change noticeASX
Ceasing to be a substantial holderAug 6, 2026Ownership change noticeASX
Becoming a substantial holderAug 4, 2026Ownership change noticeASX
Notice of FY26 result analyst and media briefingJul 28, 2026Other filingsASX
Becoming a substantial holderJul 27, 2026Ownership change noticeASX
Trading update and reduction to FY26 earnings guidanceApr 21, 2026GuidanceASX
HY26 Result - Presentation SlidesFeb 12, 2026ResultsASX
HY26 Result - ASX & Media ReleaseFeb 12, 2026Other filingsASX
Appendix 4D and Half Year Financial ReportFeb 12, 2026Interim reportASX
2025 AGM Chair and CEO & President AddressesOct 22, 2025Other filingsASX
Update - Notification of buy-back - COHAug 14, 2025Treasury share statusASX
FY25 Result - ASX & Media ReleaseAug 14, 2025ResultsASX
FY25 Result - PresentationAug 14, 2025ResultsASX
Appendix 4EAug 14, 2025ResultsASX
Cochlear provides update to FY25 earnings guidanceJun 11, 2025GuidanceASX
Cochlear statement on US tariff announcementApr 8, 2025Other filingsASX
Cochlear awaits clarification on application of US tariffApr 2, 2025Explanation requestASX
HY25 Result - ASX & Media ReleaseFeb 13, 2025Other filingsASX
HY25 Result - Presentation SlidesFeb 13, 2025Other filingsASX
2024 AGM Chair and CEO & President AddressesOct 24, 2024Other filingsASX
FY24 Result - PresentationAug 14, 2024ResultsASX
FY24 Result - ASX & Media ReleaseAug 14, 2024ResultsASX
Cochlear acquires Demant cochlear implant businessMay 21, 2024Acquisition or disposalASX
HY24 Result - Presentation SlidesFeb 18, 2024Other filingsASX
HY24 Result - ASX & Media ReleaseFeb 18, 2024ResultsASX
Cochlear Upgrades FY24 Earnings GuidanceFeb 7, 2024GuidanceASX
2023 AGM Chair and CEO & President AddressesOct 16, 2023Other filingsASX
FY23 Result - PresentationAug 14, 2023Other filingsASX
FY23 Result - ASX & Media ReleaseAug 14, 2023Other filingsASX
Oticon Medical Acquisition - UK CMA Final Report & UpdateJun 22, 2023Acquisition or disposalASX
Provisional findings from the UK CMAApr 20, 2023Other filingsASX
HY23 Result - Presentation SlidesFeb 14, 2023Other filingsASX
HY23 Result - ASX & Media ReleaseFeb 14, 2023Other filingsASX
Oticon Medical acquisition - UK CMA decisionDec 6, 2022Acquisition or disposalASX
Acquisition of Oticon Medical-ACCC StatementNov 30, 2022Acquisition or disposalASX
2022 AGM Chair and CEO & President AddressesOct 17, 2022Other filingsASX
FY22 Result PresentationAug 18, 2022Other filingsASX
FY22 Result - ASX & Media ReleaseAug 18, 2022Other filingsASX
Cochlear agrees to acquire Oticon MedicalApr 27, 2022Acquisition or disposalASX
Half Year Results PresentationFeb 21, 2022Interim reportASX
Half Year Results AnnouncementFeb 21, 2022Interim reportASX
FY21 Result - ASX & Media ReleaseAug 19, 2021Other filingsASX
Half Yearly Report and AccountsFeb 18, 2021Interim reportASX
COH HY21 Result ASX & Media ReleaseFeb 18, 2021Other filingsASX
2020 AGM - Chairman and CEO & Presidents addressOct 19, 2020Other filingsASX
First quarter trading updateOct 19, 2020Other filingsASX
FY20 result - ASX & media releaseAug 17, 2020Other filingsASX
Settlement in US Patent Infringement CaseAug 17, 2020Other filingsASX
Confirmation of COVID-19 pandemic impact on tradingMay 10, 2020Other filingsASX
Cochlear Completes Share Purchase PlanApr 28, 2020FinancingASX
Cochlear Share Purchase Plan Offer OpenMar 31, 2020FinancingASX
Successful completion of A$880M Institutional PlacementMar 25, 2020FinancingASX
Investor PresentationMar 24, 2020Other filingsASX
Cochlear Limited announces capital raising to enhance liquidMar 24, 2020FinancingASX
Trading HaltMar 24, 2020Trading halt or suspensionASX
Adverse appeal decision in the US patent infringement caseMar 16, 2020Other filingsASX
Cochlear withdraws FY20 earnings guidance due to coronavirusMar 15, 2020GuidanceASX
HY20 Result Presentation SlidesFeb 17, 2020Other filingsASX
HY20 Result ASX & Media ReleaseFeb 17, 2020Other filingsASX
Cochlear reduces earnings guidance due to coronavirusFeb 10, 2020GuidanceASX
2019 Chairmans AGM Address to ShareholdersOct 21, 2019Other filingsASX
FY19 Results ASX & Media ReleaseAug 15, 2019Other filingsASX
COH - Profile Plus FDA ApprovalJun 16, 2019Other filingsASX
Cochlear announces launch of Nucleus Profile Plus implantApr 15, 2019Other filingsASX
COH Half Year Results Analyst - 19.02.2019Feb 18, 2019Interim reportASX
COH Half Year Results Media Release - 19.02.2019Feb 18, 2019Interim reportASX
COH - Ruling in USA Patent Infringement CaseNov 4, 2018Other filingsASX
2018 Chairmans AGM Address to ShareholdersOct 15, 2018Other filingsASX
Next phase development - totally implantable cochlear deviceOct 9, 2018Other filingsASX
COH FY18 Result AnnouncementAug 13, 2018Other filingsASX
Full Year Statutory Accounts - COH Appendix 4EAug 13, 2018Annual reportASX
COH announces release of Nucleus Smart App for AndroidJun 22, 2018Other filingsASX
COH Half Year Results Analyst PresentationFeb 12, 2018Interim reportASX
COH Half Year Results Media Release 13.02.2018Feb 12, 2018Interim reportASX
Half Year AccountsFeb 12, 2018Interim reportASX
COH CEO Transition and Related Board ChangesNov 13, 2017Other filingsASX
2017 Chairmans AGM Address to ShareholdersOct 16, 2017Other filingsASX
COH FY17 Result AnnouncementAug 16, 2017Other filingsASX
COCHLEAR TO EXPAND GLOBAL CAPACITYJul 13, 2017Other filingsASX
Cochlear acquires audiology practice management softwareMay 10, 2017Acquisition or disposalASX
COH Half Year Results Media ReleaseFeb 13, 2017Interim reportASX
Decision in US Patent Infringement CaseNov 17, 2016Other filingsASX
2016 Chairmans AGM Address to ShareholdersOct 17, 2016Other filingsASX
COH FY16 Result AnnouncementAug 8, 2016Other filingsASX
COH Clinic Update LetterMar 30, 2016Other filingsASX
Settlement Agreement with the DOJ and OIGMar 30, 2016Other filingsASX
Response to ASX Price QueryMar 30, 2016Explanation requestASX
COH Half Year Report as at 31 December 2009 09.02.10Mar 30, 2016Interim reportASX
Half Year Report and AccountsMar 30, 2016Interim reportASX
COH - F10 Preliminary Final Report - Appendix 4EMar 30, 2016ResultsASX
18/10/11 Chairman`s AGM Address to ShareholdersMar 30, 2016Other filingsASX
Preliminary Final Report Appendix 4EMar 30, 2016ResultsASX
Half Year Report & AccountsFeb 11, 2016Interim reportASX
Full Year Statutory Accounts and Annual ReportFeb 11, 2016Annual reportASX
COH Chris Smith Announced as Incoming CEO of CochlearFeb 11, 2016Other filingsASX
Judgment in United States Patent Infringement LawsuitFeb 11, 2016Other filingsASX
DECISION IN US PATENT INFRINGEMENT CASEFeb 11, 2016Other filingsASX
COH Full Year Results Media Release 05.08.14Feb 10, 2016ResultsASX
Preliminary Final Report and Full Year Statutory AccountsFeb 10, 2016Annual reportASX
COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROPFeb 10, 2016Other filingsASX
FDA approves Cochlear Nucleus Hybrid for sale in USAFeb 10, 2016Other filingsASX
COH Jury Trial Verdict on USA Patent Infringement CaseFeb 10, 2016Other filingsASX
Hybrid Hearing Device UpdateFeb 10, 2016Other filingsASX
15/10/13 Chairmans AGM Address to ShareholdersFeb 10, 2016Other filingsASX
Full Year Statutory AccountsFeb 10, 2016Annual reportASX
Cochlear Limited Market UpdateFeb 10, 2016Other filingsASX
COH Update on Nucleus CI500 series implant recallFeb 10, 2016Other filingsASX
Appendix 4E and Full Year Statutory AccountsFeb 10, 2016Annual reportASX
Cochlear Voluntary RecallFeb 10, 2016Other filingsASX

Open Filings

Cap table

Built by 6ix from Cochlear Limited’s releases

Common shares
65,398,917
Fully diluted
65,398,917

Fully diluted

LineShares
Common shares65,398,917

Share count over time

CountShares
Nov 22, 202665,398,917

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
GAMMA Investing LLC2,613US$125KSep 30, 2026
Calydon Capital284US$13,572Sep 30, 2026
Rhumbline Advisers180US$8,602Sep 30, 2026
Ascentis Wealth Management, LLC22US$1,051Sep 30, 2026
PNC Financial Services Group, Inc.15US$717Sep 30, 2026

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund968KUS$81.2MJul 31, 2026
Vanguard Developed Markets Index Fund637KUS$53.5MJun 30, 2026
T. Rowe Price International Value Equity Fund570KUS$47.8MJul 31, 2026
iShares Core MSCI EAFE ETF485KUS$40.7MJul 31, 2026
BNY Mellon International Stock Fund319KUS$23.1MMay 31, 2026
Invesco International Small-Mid Company Fund275KUS$23MJul 31, 2026
Fidelity International Index Fund246KUS$17.8MMay 31, 2026
iShares MSCI EAFE ETF225KUS$18.9MJul 31, 2026
T. Rowe Price International Discovery Fund200KUS$16.7MJul 31, 2026
Schwab International Equity ETF157KUS$11.4MMay 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard Ftse All-World Ex-Us Index Fund156KUS$13MJul 31, 2026
Goldman Sachs ActiveBeta(R) International Equity ETF144KUS$10.4MMay 31, 2026
iShares ESG Aware MSCI EAFE ETF137KUS$9.84MMay 31, 2026
Fidelity Series Global ex U.S. Index Fund129KUS$10.8MJul 31, 2026
Invesco Global Opportunities Fund113KUS$9.5MJul 31, 2026
Nuveen International Equity Index Fund103KUS$8.66MJul 31, 2026
iShares MSCI EAFE Growth ETF101KUS$8.43MJul 31, 2026
iShares Core MSCI Total International Stock ETF89,020US$7.46MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF84,644US$7.14MJun 30, 2026
iShares Core MSCI International Developed Markets ETF71,498US$5.99MJul 31, 2026
Vanguard Pacific Stock Index Fund70,477US$5.91MJul 31, 2026
iShares MSCI Australia ETF66,068US$4.76MMay 31, 2026
International Core Equity 2 Portfolio60,740US$5.09MJul 31, 2026
iShares MSCI Pacific ex Japan ETF60,597US$4.36MMay 31, 2026
Vanguard Total World Stock Index Fund54,701US$4.58MJul 31, 2026
Bridge Builder Tax Managed International Equity Fund53,606US$4.5MJun 30, 2026
Schwab International Index Fund45,800US$3.84MJul 31, 2026
iShares MSCI EAFE International Index Fund42,251US$3.55MJun 30, 2026
iShares MSCI Intl Quality Factor ETF39,688US$3.33MJul 31, 2026
Fidelity Total International Index Fund38,767US$3.25MJul 31, 2026
FlexShares International Quality Dividend Index Fund34,980US$2.95MJul 31, 2026
DWS CROCI (R) International Fund34,769US$2.51MMay 31, 2026
Fidelity Global ex U.S. Index Fund34,336US$2.88MJul 31, 2026
iShares Global Healthcare ETF33,376US$2.8MJun 30, 2026
Multi-Manager International Equity Strategies Fund30,750US$2.21MMay 31, 2026
Variable Portfolio - Partners International Growth Fund27,800US$2.34MJun 30, 2026
Fidelity SAI International Quality Index Fund27,552US$2.31MJul 31, 2026
Fidelity SAI International Index Fund27,368US$2.29MJul 31, 2026
Xtrackers MSCI EAFE Hedged Equity ETF25,527US$1.84MMay 29, 2026
Goldman Sachs ActiveBeta World Equity ETF25,009US$1.81MMay 31, 2026
iShares MSCI ACWI ETF22,743US$1.91MJul 31, 2026
Hartford Multifactor Developed Markets (ex-US) ETF21,273US$1.79MJul 31, 2026
iShares MSCI ACWI ex U.S. ETF20,092US$1.68MJul 31, 2026
Fidelity ZERO International Index Fund19,729US$1.65MJul 31, 2026
International Equity Index Fund19,624US$1.66MJun 30, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio18,517US$1.56MJun 30, 2026
iShares Core MSCI Pacific ETF18,060US$1.51MJul 31, 2026
International Opportunities Fund17,877US$1.29MMay 31, 2026
Schwab Fundamental International Small Equity ETF17,181US$1.24MMay 31, 2026
International Sustainability Core 1 Portfolio17,085US$1.43MJul 31, 2026

This page holds 50 of 197 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Michael del Prado
Director
Buy235USD 102.26US$24,031Nov 16, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chris SmithChief Executive Officer · Sep 11, 2025 – Nov 5, 2026 · Past

Open People

Log in to ask 6ix AI your own questions about Cochlear Limited.